Target intelligence / Profile preview

MORC family CW-type zinc finger 2 (MORC2)

Target
MORC2
Molecular classification
Chromatin remodeling enzyme, ATPase, Zinc finger protein, Epigenetic regulator, Transcriptional repressor, Protein coding gene
01

Overview

MORC family CW-type zinc finger 2 (MORC2) is a chromatin remodeling enzyme encoded by the human MORC2 gene. It contains an N-terminal GHKL-type ATPase domain, a central CW-type zinc finger domain, coiled-coil domains, and a C-terminal chromo-like domain. MORC2 is predominantly nuclear and participates in heterochromatin condensation, epigenetic gene silencing via the HUSH complex, and transcriptional repression. Its ATPase and chromatin remodeling activities are essential for an effective DNA damage response, notably through interaction and reciprocal regulation with poly(ADP-ribose) polymerase 1 (PARP1). In the cytoplasm, MORC2 also plays a role in glucose and lipid metabolism. Pathogenic heterozygous mutations in MORC2 cause distinct genetic neuropathies such as Charcot-Marie-Tooth disease type 2Z and DIGFAN syndrome, as well as being implicated in several cancers due to its ability to affect gene expression and cellular metabolic pathways[1][3][4][5][7].

Other names
Microrchidia family CW-type zinc finger 2MORC2
02

Mechanism of action

Not a direct therapeutic target, but MORC2 modulates chromatin structure and gene expression and may be involved in the cellular response to genotoxic therapies (e.g., via interaction with PARP1 in DNA damage response)[7][1].

03

Biological functions

Chromatin remodelingDNA damage repairTranscriptional repressionEpigenetic gene silencingLipogenesis and adipocyte differentiationCell cycle regulation
04

Disease associations

Peripheral neuropathy (e.g., Charcot-Marie-Tooth disease type 2Z)Neurodevelopmental syndromes (e.g., DIGFAN syndrome)Cancer (notably as a potential oncogene in some cancers)Other inherited neuropathies
05

Safety considerations

No direct safety concerns described, but mutations can cause severe neuropathic and neurodevelopmental disorders by impairing chromatin remodeling and DNA repair[1][2].
06

Biomarkers

Mutations in MORC2 are used as diagnostic biomarkers for Charcot-Marie-Tooth disease type 2Z and specific neurodevelopmental syndromes[1][2][4].

Beyond the preview

Go deeper on MORC family CW-type zinc finger 2 (MORC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MORC family CW-type zinc finger 2 (MORC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call